Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Øystein Bruserud

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Current Topics in Microbiology and Immunology|October 26, 2010
The chemokine system in experimental and clinical hematology. PrefaceØystein Bruserud
Expert Opinion on Therapeutic Targets|October 15, 2010
Therapeutic targeting of NF-κB in myelodysplastic syndromes and acute myeloid leukaemia - the biological heterogeneityØystein Bruserud, Håkon Reikvam
Expert Review of Hematology|January 29, 2019
Thrombotic complications in adult patients with severe single coagulation factor or platelet defects - an overviewHanne Skaadel, Øystein Bruserud
Current Medicinal Chemistry|March 26, 2019
Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other TreatmentsEva Leufven, Øystein Bruserud
Leukemia Research|July 20, 2010
Heat shock protein 90 (HSP90) inhibition--from experimental to clinical studiesØystein Bruserud, Håkon Reikvam
Expert Opinion on Biological Therapy|October 22, 2002
A critical review of T cell targeting immunotherapy in pancreatic cancer: only a hypothesis or a real hope for the patients?Øystein Bruserud, Nils Glenjen
Cells|September 26, 2025
NUP214 in Acute Myeloid LeukemiaØystein Bruserud, Håkon Reikvam
Cancers|July 29, 2023
Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid LeukemiaØystein Bruserud, Håkon Reikvam
Journal of Hematotherapy & Stem Cell Research|November 5, 2003
Functional evaluation of proliferative T cell responses in patients with severe T lymphopenia: characterization of optimal culture conditions and standardized activation signals for a simple whole blood assayØystein Wendelbo, Øystein Bruserud
Current Pharmaceutical Biotechnology|February 22, 2008
Epigenetic targeting in acute myeloid leukemia: use of flow cytometry in monitoring therapeutic effectsAnita Ryningen, Øystein Bruserud
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Current Topics in Microbiology and Immunology|October 26, 2010
The chemokine system in experimental and clinical hematology. PrefaceØystein Bruserud
Expert Opinion on Therapeutic Targets|October 15, 2010
Therapeutic targeting of NF-κB in myelodysplastic syndromes and acute myeloid leukaemia - the biological heterogeneityØystein Bruserud, Håkon Reikvam
Expert Review of Hematology|January 29, 2019
Thrombotic complications in adult patients with severe single coagulation factor or platelet defects - an overviewHanne Skaadel, Øystein Bruserud
Current Medicinal Chemistry|March 26, 2019
Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other TreatmentsEva Leufven, Øystein Bruserud
Leukemia Research|July 20, 2010
Heat shock protein 90 (HSP90) inhibition--from experimental to clinical studiesØystein Bruserud, Håkon Reikvam
Expert Opinion on Biological Therapy|October 22, 2002
A critical review of T cell targeting immunotherapy in pancreatic cancer: only a hypothesis or a real hope for the patients?Øystein Bruserud, Nils Glenjen
Cells|September 26, 2025
NUP214 in Acute Myeloid LeukemiaØystein Bruserud, Håkon Reikvam
Cancers|July 29, 2023
Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid LeukemiaØystein Bruserud, Håkon Reikvam
Journal of Hematotherapy & Stem Cell Research|November 5, 2003
Functional evaluation of proliferative T cell responses in patients with severe T lymphopenia: characterization of optimal culture conditions and standardized activation signals for a simple whole blood assayØystein Wendelbo, Øystein Bruserud
Current Pharmaceutical Biotechnology|February 22, 2008
Epigenetic targeting in acute myeloid leukemia: use of flow cytometry in monitoring therapeutic effectsAnita Ryningen, Øystein Bruserud
Pageof 24